According to the last NCCN Guidelines, the results of our study confirm the recommendation to test for BRCA genes in TNBC patients ≤ 60 years, regardless of family history, tumor histotype and by using immunohistochemical staining of less than 10% of nuclei for both ER and/PR as a cut-off. The gene discussed is ESR1; the disease is neoplasm.